Our results showed serum Egfl7 levels was modestly elevated in patients with CLD compared with healthy individuals (1600.3 ng/mL vs. 1082.80 ng/mL) but much lower than those with early HCC (4017.28 ng/mL). The gene discussed is EGFL7; the disease is hepatocellular carcinoma.